Report Detail

TABLE OF CONTENTS

    1. Introduction

    • 1.1 Scope Of The Study
    • 1.2 The Insight Partners Research Report Guidance

    2. Asia Pacific Drug Delivery Systems Market - Key Takeaways

      3. Asia Pacific Drug Delivery Systems Market - Market Landscape

      • 3.1 Overview
      • 3.2 Market Segmentation
        • 3.2.1 Asia Pacific Drug Delivery Systems Market - By Route Of Administration
        • 3.2.2 Asia Pacific Drug Delivery Systems Market - By Application
        • 3.2.3 Asia Pacific Drug Delivery Systems Market - By Distribution Channel
        • 3.2.4 Asia Pacific Drug Delivery Systems Market - By Country
      • 3.3 Pest Analysis

      4. Asia Pacific Drug Delivery Systems Market - Key Market Dynamics

      • 4.1 Key Market Drivers
        • 4.1.1 Rapid Technological Advancements in Diabetes Care Devices
        • 4.1.2 Increasing Rate of Obesity
      • 4.2 Key Market Restraints
        • 4.2.1 Increasing Reuse Of Pen Needles
      • 4.3 Key Market Opportunities
        • 4.3.1 Growing Medical Tourism In Developing Countries
      • 4.4 Future Trends
        • 4.4.1 Adoption Of Advanced Technology
      • 4.5 Impact Analysis

      5. Drug Delivery Systems Market - Asia Pacific Analysis

      • 5.1 Asia Pacific Drug Delivery Systems Market Revenue Forecasts And Analysis
      • 5.2 Market Positioning
        • 5.2.1 BD
        • 5.2.2 3M
        • 5.2.3 Glaxosmithkline Plc.
        • 5.2.4 Novartis Ag

      6. Asia Pacific Drug Delivery Systems Market Analysis - By Route Of Administration

      • 6.1 Overview
      • 6.2 Asia Pacific Drug Delivery Systems Market By Route Of Administration, 2018 & 2027 (%)
      • 6.3 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
        • 6.3.1 Asia Pacific Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        • 6.3.2 Asia Pacific Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        • 6.3.3 Asia Pacific Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        • 6.3.4 Asia Pacific Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
          • 6.3.4.1 Asia Pacific Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        • 6.3.5 Asia Pacific Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        • 6.3.6 Asia Pacific Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        • 6.3.7 Asia Pacific Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        • 6.3.8 Asia Pacific Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
      • 6.4 Oral Drug Delivery Market
        • 6.4.1 Overview
        • 6.4.2 Oral Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
        • 6.4.3 Solid Oral Drugs Market
          • 6.4.3.1 Overview
          • 6.4.3.2 Solid Oral Drugs Market Revenue And Forecast To 2027 (US$ Mn)
          • 6.4.3.3 Solid Oral Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
        • 6.4.4 Liquid Oral Drugs Market
          • 6.4.4.1 Overview
          • 6.4.4.2 Liquid Oral Drugs Market Revenue And Forecast To 2027 (US$ Mn)
          • 6.4.4.3 Liquid Oral Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
        • 6.4.5 Semi-Solid Oral Drugs Market
          • 6.4.5.1 Overview
          • 6.4.5.2 Semi-Solid Oral Drugs Market Revenue And Forecast To 2027 (US$ Mn)
          • 6.4.5.3 Semi-Solid Oral Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
      • 6.5 Transmucosal Drug Delivery Market
        • 6.5.1 Overview
        • 6.5.2 Transmucosal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
        • 6.5.3 Pulmonary Drug Delivery Market
          • 6.5.3.1 Overview
          • 6.5.3.2 Pulmonary Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
          • 6.5.3.3 Pulmonary Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
          • 6.5.3.4 In-Metered Dose Inhalers Market
          • 6.5.3.4.1 Overview
          • 6.5.3.4.2 In-metered Dose Inhalers Market Revenue and Forecast to 2027 (US$ Mn)
          • 6.5.3.5 Dry Powder Inhalers Market
          • 6.5.3.5.1 Overview
          • 6.5.3.5.2 Dry Powder Inhalers Market Revenue and Forecast to 2027 (US$ Mn)
          • 6.5.3.6 Nebulizers Market
          • 6.5.3.6.1 Overview
          • 6.5.3.6.2 Nebulizers Market Revenue and Forecast to 2027 (US$ Mn)
          • 6.5.4 Nasal Drug Delivery Market
            • 6.5.4.1 Overview
            • 6.5.4.2 Nasal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
            • 6.5.4.3 Nasal Spray Market
            • 6.5.4.3.1 Overview
            • 6.5.4.3.2 Nasal Spray Market Revenue and Forecast to 2027 (US$ Mn)
            • 6.5.4.4 Nasal Drops Market
            • 6.5.4.4.1 Overview
            • 6.5.4.4.2 Nasal Drops Market Revenue and Forecast to 2027 (US$ Mn)
            • 6.5.4.5 Nasal Gel Market
            • 6.5.4.5.1 Overview
            • 6.5.4.5.2 Nasal Gel Market Revenue and Forecast to 2027 (US$ Mn)
            • 6.5.5 Buccal Drug Delivery Market
              • 6.5.5.1 Overview
              • 6.5.5.2 Buccal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
            • 6.5.6 Sublingual Drug Delivery Market
              • 6.5.6.1 Overview
              • 6.5.6.2 Sublingual Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
            • 6.5.7 Rectal Transmucosal Drug Delivery Market
              • 6.5.7.1 Overview
              • 6.5.7.2 Rectal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
            • 6.5.8 Vaginal Transmucosal Drug Delivery Market
              • 6.5.8.1 Overview
              • 6.5.8.2 Vaginal Transmucosal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
          • 6.6 Topical Drug Delivery Market
            • 6.6.1 Overview
            • 6.6.2 Topical Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
            • 6.6.3 Semi-Solid Topical Drug Delivery Formulations Market
              • 6.6.3.1 Overview
              • 6.6.3.2 Semi-Solid Topical Drug Delivery Formulations Market Revenue And Forecast To 2027 (US$ Mn)
            • 6.6.4 Liquid Topical Drug Delivery Formulations Market
              • 6.6.4.1 Overview
              • 6.6.4.2 Liquid Topical Drug Delivery Formulations Market Revenue And Forecast To 2027 (US$ Mn)
            • 6.6.5 Solid Topical Drug Delivery Formulations Market
              • 6.6.5.1 Overview
              • 6.6.5.2 Solid Topical Drug Delivery Formulations Market Revenue And Forecast To 2027 (US$ Mn)
            • 6.6.6 Transdermal Patches Market
              • 6.6.6.1 Overview
              • 6.6.6.2 Transdermal Patches Market Revenue And Forecast To 2027 (US$ Mn)
            • 6.6.7 Transdermal Gels Market
              • 6.6.7.1 Overview
              • 6.6.7.2 Transdermal Gels Market Revenue And Forecast To 2027 (US$ Mn)
            • 6.6.8 Others Market
              • 6.6.8.1 Overview
              • 6.6.8.2 Others Market Revenue And Forecast To 2027 (US$ Mn)
          • 6.7 Injectable Drug Delivery Market
            • 6.7.1 Overview
            • 6.7.2 Injectable Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
            • 6.7.3 Conventional Injection Devices Market
              • 6.7.3.1 Overview
              • 6.7.3.2 Conventional Injection Devices Market Revenue And Forecast To 2027 (US$ Mn)
            • 6.7.4 Self-Injection Devices Market
              • 6.7.4.1 Overview
              • 6.7.4.2 Self-Injection Devices Market Revenue And Forecast To 2027 (US$ Mn)
              • 6.7.4.3 Needle Free Injectors Market
              • 6.7.4.3.1 Overview
              • 6.7.4.3.2 Needle Free Injectors Market Revenue and Forecast to 2027 (US$ Mn)
              • 6.7.4.4 Pen Injectors Market
              • 6.7.4.4.1 Overview
              • 6.7.4.4.2 Pen injectors Market Revenue and Forecast to 2027 (US$ Mn)
              • 6.7.4.5 Wearable Injectors Market
              • 6.7.4.5.1 Overview
              • 6.7.4.5.2 Wearable Injectors Market Revenue and Forecast to 2027 (US$ Mn)
              • 6.8 Implantable Drug Delivery Market
                • 6.8.1 Overview
                • 6.8.2 Implantable Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
                • 6.8.3 Active Implantable Market
                  • 6.8.3.1 Overview
                  • 6.8.3.2 Active Implantable Market Revenue And Forecast To 2027 (US$ Mn)
                • 6.8.4 Passive Implantable Market
                  • 6.8.4.1 Overview
                  • 6.8.4.2 Passive Implantable Market Revenue And Forecast To 2027 (US$ Mn)
              • 6.9 Ocular Drug Delivery Market
                • 6.9.1 Overview
                • 6.9.2 Ocular Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
                • 6.9.3 Eye Drops And Sprays Market
                  • 6.9.3.1 Overview
                  • 6.9.3.2 Eye Drops And Sprays Market Revenue And Forecast To 2027 (US$ Mn)
                • 6.9.4 Gels & Ointments Market
                  • 6.9.4.1 Overview
                  • 6.9.4.2 Gels & Ointments Market Revenue And Forecast To 2027 (US$ Mn)
                • 6.9.5 Ocular Inserts Market
                  • 6.9.5.1 Overview
                  • 6.9.5.2 Ocular Inserts Market Revenue And Forecast To 2027 (US$ Mn)
                • 6.9.6 Drug Coated Contact Lens Market
                  • 6.9.6.1 Overview
                  • 6.9.6.2 Drug Coated Contact Lens Market Revenue And Forecast To 2027 (US$ Mn)

                7. Asia Pacific Drug Delivery Systems Market Analysis - By Application

                • 7.1 Overview
                • 7.2 Asia Pacific Endodontic Devices Market Share By Application 2018 & 2027 (%)
                • 7.3 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
                • 7.4 Homecare Settings Market
                  • 7.4.1 Overview
                  • 7.4.2 Homecare Settings Market Revenue And Forecasts To 2027 (US$ Mn)
                • 7.5 Hospitals & Clinics Market
                  • 7.5.1 Overview
                  • 7.5.2 Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)
                • 7.6 Others Market
                  • 7.6.1 Overview
                  • 7.6.2 Others Market Revenue And Forecasts To 2027 (US$ Mn)

                8. Asia Pacific Drug Delivery Systems Market Analysis - By Distribution Channel

                • 8.1 Overview
                • 8.2 Asia Pacific Endodontic Devices Market Share By Distribution Channel 2018 & 2027 (%)
                • 8.3 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
                • 8.4 Homecare Settings Market
                  • 8.4.1 Overview
                  • 8.4.2 Homecare Settings Market Revenue And Forecasts To 2027 (US$ Mn)
                • 8.5 Hospital Pharmacies Market
                  • 8.5.1 Overview
                  • 8.5.2 Hospital Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)
                • 8.6 Retail Pharmacies Market
                  • 8.6.1 Overview
                  • 8.6.2 Retail Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)
                • 8.7 Online Pharmacies Market
                  • 8.7.1 Overview
                  • 8.7.2 Online Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)

                9. Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027

                • 9.1 Overview
                  • 9.1.1 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
                  • 9.1.2 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
                    • 9.1.2.1 Asia Pacific Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
                    • 9.1.2.2 Asia Pacific Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
                    • 9.1.2.3 Asia Pacific Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
                    • 9.1.2.4 Asia Pacific Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
                    • 9.1.2.4.1 Asia Pacific Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.2.5 Asia Pacific Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
                    • 9.1.2.6 Asia Pacific Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
                    • 9.1.2.7 Asia Pacific Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
                    • 9.1.2.8 Asia Pacific Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
                  • 9.1.3 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
                  • 9.1.4 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
                  • 9.1.5 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Country (%)
                  • 9.1.6 China Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
                  • 9.1.7 China Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
                    • 9.1.7.1 China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
                    • 9.1.7.1.1 China Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.7.1.2 China Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.7.1.3 China Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.7.1.4 China Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.7.1.5 China Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.7.1.6 China Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.7.1.7 China Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.7.1.8 China Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.7.1.9 China Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.7.2 China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
                    • 9.1.7.3 China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
                  • 9.1.8 Japan Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
                  • 9.1.9 Japan Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
                    • 9.1.9.1 Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
                    • 9.1.9.1.1 Japan Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.9.1.2 Japan Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.9.1.3 Japan Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.9.1.4 Japan Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.9.1.5 Japan Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.9.1.6 Japan Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.9.1.7 Japan Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.9.1.8 Japan Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.9.1.9 Japan Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.9.2 Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
                    • 9.1.9.3 Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
                  • 9.1.10 India Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
                  • 9.1.11 India Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
                    • 9.1.11.1 India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
                    • 9.1.11.1.1 India Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.11.1.2 India Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.11.1.3 India Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.11.1.4 India Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.11.1.5 India Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.11.1.6 India Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.11.1.7 India Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.11.1.8 India Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.11.1.9 India Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
                    • 9.1.11.2 India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
                    • 9.1.11.3 India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

                  10. Drug Delivery Systems Market - Industry Landscape

                  • 10.1 Overview
                  • 10.2 Comparative Company Analysis
                  • 10.3 Growth Strategies done by the companies in the Market, (%)
                  • 10.4 Organic Developments
                    • 10.4.1 Overview
                  • 10.5 Inorganic developments
                    • 10.5.1 Overview

                  11. Drug Delivery Systems Market-Key Company Profiles

                  • 11.1 3M
                    • 11.1.1 Key Facts
                    • 11.1.2 Business Description
                    • 11.1.3 Financial Overview
                    • 11.1.4 Product Portfolio
                    • 11.1.5 SWOT Analysis
                    • 11.1.6 Key Developments
                  • 11.2 BD
                    • 11.2.1 Key Facts
                    • 11.2.2 Business Description
                    • 11.2.3 Financial Overview
                    • 11.2.4 Product Portfolio
                    • 11.2.5 SWOT Analysis
                    • 11.2.6 Key Developments
                  • 11.3 Boston Scientific Corporation
                    • 11.3.1 Key Facts
                    • 11.3.2 Business Description
                    • 11.3.3 Financial Overview
                    • 11.3.4 Product Portfolio
                    • 11.3.5 SWOT Analysis
                    • 11.3.6 Key Developments
                  • 11.4 Novo Nordisk A/S
                    • 11.4.1 Key Facts
                    • 11.4.2 Business Description
                    • 11.4.3 Financial Overview
                    • 11.4.4 Product Portfolio
                    • 11.4.5 SWOT Analysis
                    • 11.4.6 Key Developments
                  • 11.5 Bausch Health Companies Inc.
                    • 11.5.1 Key Facts
                    • 11.5.2 Business Description
                    • 11.5.3 Financial Overview
                    • 11.5.4 Product Portfolio
                    • 11.5.5 SWOT Analysis
                    • 11.5.6 Key Developments
                  • 11.6 BAxter International, Inc.
                    • 11.6.1 Key Facts
                    • 11.6.2 Business Description
                    • 11.6.3 Financial Overview
                    • 11.6.4 Product Portfolio
                    • 11.6.5 SWOT Analysis
                    • 11.6.6 Key Developments
                  • 11.7 Boehringer Ingelheim International GmbH
                    • 11.7.1 Key Facts
                    • 11.7.2 Business Description
                    • 11.7.3 Financial Overview
                    • 11.7.4 Product Portfolio
                    • 11.7.5 SWOT Analysis
                    • 11.7.6 Key Developments
                  • 11.8 Novartis AG
                    • 11.8.1 Key Facts
                    • 11.8.2 Business Description
                    • 11.8.3 Financial Information
                    • 11.8.4 Product Portfolio
                    • 11.8.5 SWOT Analysis
                    • 11.8.6 Key Developments
                  • 11.9 GlaxoSmithKline plc.
                    • 11.9.1 Key Facts
                    • 11.9.2 Business Description
                    • 11.9.3 Financial Overview
                    • 11.9.4 Product Portfolio
                    • 11.9.5 SWOT Analysis
                    • 11.9.6 Key Developments
                  • 11.10 Terumo Corporation
                    • 11.10.1 Key Facts
                    • 11.10.2 Business Description
                    • 11.10.3 Financial Overview
                    • 11.10.4 Product portfolio
                    • 11.10.5 SWOT ANALYSIS
                    • 11.10.6 KEY DEVELOPMENTS
                  • 11.11 Johnson & Johnson Services, Inc.
                    • 11.11.1 Key Facts
                    • 11.11.2 Business Description
                    • 11.11.3 Financial Overview
                    • 11.11.4 Product Portfolio
                    • 11.11.5 Swot Analysis
                    • 11.11.6 Key Developments

                  12. Appendix

                  • 12.1 About The Insight Partners
                  • 12.2 Glossary Of Terms

                  13. Glossary of Terms, Drug delivery systems market

                  • 13.1 Methodology
                    • 13.1.1 Coverage
                    • 13.1.2 Secondary Research

      The Asia Pacific drug delivery systems market is expected to reach US$ 441,337.0 Mn in 2027 from US$ 212,012.7 Mn in 2018. The market is estimated to grow with a CAGR of 8.6% from 2019-2027.
      The growth of the drug delivery systems market is primarily attributed to the rapid technological advancements in diabetes care devices and increasing rate of obesity. However, increasing reuse of pen needles is likely to pose a negative impact on the market growth. On the other hand, growing medical tourism in the emerging nations is likely to have a positive impact on the growth of the Asia Pacific drug delivery systems market in the coming years.
      The advancement in the field of the healthcare industry is driving to the players for more research and developments for the drug delivery systems for the administration purpose required during various medical conditions. The pen needles used in various injection pens have evolved gradually in terms of material, performance, dimensions and safety factors such as sterility and safety packaging. Various manufacturers are coming up with innovative products to sustain in the highly fragmented drug delivery systems market, in the region. Moreover, the easy regulatory approvals in the Asian countries has led to mid-sized companies enter the market and compete with the local and established players. For instance, in May 2018, Hindustan Syringes and Medical Devices (HMD), one of the leading manufacturers of disposable syringes introduced “Dispovan” insulin pen needle which is the first made-in-India disposable pen needle that is technologically efficient and affordable than that of the currently available products in the market. Development of pen needles with precise lubrication to reduce the pain sensation has been another focus of manufacturers during the research. Thus, owing to the above mentioned factors the market for drug delivery systems anticipated to grow rapidly in the forecast period, in the region.
      In 2018, the oral segment held a largest market share of 50.2% of the drug delivery systems market, by route of administration. The oral segment is expected to dominate its market share in 2027 owing to ease of drug administration, high degree of flexibility on dosages and cost effectiveness.
      In 2018, the hospitals and clinics held a largest market share of 56.0% of the drug delivery systems market, by application. This segment is also expected to dominate the market in 2027 owing to the large number of patient population visiting hospitals and clinics. Also hospitals provide diagnosis and treatment for various medical conditions.
      In 2018, the hospitals pharmacies held a largest market share of 68.7% of the drug delivery systems market, by distribution channel. This segment is also expected to dominate the market in 2027 as hospital pharmacies provide larger range of medications, including more specialized and investigational medications.
      Some of the major primary and secondary sources for drug delivery systems included in the report are, Chinese Academy of Sciences (CAS), Centers for Diabetes and Endocrinology (CDE), China Initiative for Diabetes Excellence (CIDE), Vision Health Initiative (VHI) and others.


      Summary:
      Get latest Market Research Reports on Asia Pacific Drug Delivery Systems. Industry analysis & Market Report on Asia Pacific Drug Delivery Systems is a syndicated market report, published as Asia Pacific Drug Delivery Systems Market to 2027 - Regional Analysis and Forecasts by Route of Administration (Transmucosal, Oral, Injectable, Topical, Implantable, and Ocular); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); and Application (Home Care Settings, Hospitals & Clinics, and Others), and Country. It is complete Research Study and Industry Analysis of Asia Pacific Drug Delivery Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,000.00
      $4,000.00
      $5,000.00
      2,317.79
      3,090.38
      3,862.98
      2,712.03
      3,616.04
      4,520.06
      326,496.00
      435,328.00
      544,160.00
      215,317.80
      287,090.40
      358,863.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report